8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213900-21-023517
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea140117_8k-elitepharma.htm…